244 related articles for article (PubMed ID: 16920569)
1. Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapy.
Martinez-Gamboa L; Brezinschek HP; Burmester GR; Dörner T
Autoimmun Rev; 2006 Aug; 5(7):437-42. PubMed ID: 16920569
[TBL] [Abstract][Full Text] [Related]
2. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
Dörner T
J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
[TBL] [Abstract][Full Text] [Related]
3. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis.
Magalhães R; Stiehl P; Morawietz L; Berek C; Krenn V
Virchows Arch; 2002 Nov; 441(5):415-27. PubMed ID: 12447670
[TBL] [Abstract][Full Text] [Related]
4. B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives.
Nakken B; Munthe LA; Konttinen YT; Sandberg AK; Szekanecz Z; Alex P; Szodoray P
Autoimmun Rev; 2011 Nov; 11(1):28-34. PubMed ID: 21777703
[TBL] [Abstract][Full Text] [Related]
5. Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia.
Atkins SR; Turesson C; Myers JL; Tazelaar HD; Ryu JH; Matteson EL; Bongartz T
Arthritis Rheum; 2006 Feb; 54(2):635-41. PubMed ID: 16447242
[TBL] [Abstract][Full Text] [Related]
6. [The humoral response in rheumatoid arthritis and the effect of B-cell depleting therapy].
Thurlings RM; Vos K; Gerlag DM; Tak PP
Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1657-61. PubMed ID: 16922350
[TBL] [Abstract][Full Text] [Related]
7. B cells in rheumatoid arthritis.
Bugatti S; Codullo V; Caporali R; Montecucco C
Autoimmun Rev; 2007 Aug; 6(7):482-7. PubMed ID: 17643937
[TBL] [Abstract][Full Text] [Related]
8. [B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis].
Yukawa N; Mimori T
Clin Calcium; 2007 Apr; 17(4):569-76. PubMed ID: 17404487
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
Teng YK; Levarht EW; Hashemi M; Bajema IM; Toes RE; Huizinga TW; van Laar JM
Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
[TBL] [Abstract][Full Text] [Related]
10. B cells in rheumatoid arthritis.
Bugatti S; Codullo V; Caporali R; Montecucco C
Autoimmun Rev; 2007 Dec; 7(2):137-42. PubMed ID: 18035324
[TBL] [Abstract][Full Text] [Related]
11. B cells: a fundamental role in the pathogenesis of rheumatoid arthritis?
Panayi GS
Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii3-ii7. PubMed ID: 15851524
[TBL] [Abstract][Full Text] [Related]
12. B cell-targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application.
Mease PJ
J Rheumatol; 2008 Jul; 35(7):1245-55. PubMed ID: 18609733
[TBL] [Abstract][Full Text] [Related]
13. [Intra-articular B-cells in the pathogenesis of rheumatoid arthritis].
Krenn V; Molitoris R; Sack U; Gross U; Vollmers HP; König A; Fork M; Berek C; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1996; 80():58-66. PubMed ID: 9065055
[TBL] [Abstract][Full Text] [Related]
14. B-cell activation and development within chronically inflamed synovium in rheumatoid and reactive arthritis.
Berek C; Kim HJ
Semin Immunol; 1997 Aug; 9(4):261-8. PubMed ID: 9237933
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
[TBL] [Abstract][Full Text] [Related]
16. Depletion of B lymphocytes in rheumatoid arthritis patients modifies IL-8-anti-IL-8 autoantibody network.
Keren Z; Braun-Moscovici Y; Markovits D; Rozin A; Nahir M; Balbir-Gurman A; Melamed D
Clin Immunol; 2009 Oct; 133(1):108-16. PubMed ID: 19632157
[TBL] [Abstract][Full Text] [Related]
17. The role of B cells in the pathogenesis of rheumatoid arthritis.
Kotzin BL
J Rheumatol Suppl; 2005 Feb; 73():14-8; discussion 29-30. PubMed ID: 15693111
[TBL] [Abstract][Full Text] [Related]
18. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
Levesque MC; St Clair EW
J Allergy Clin Immunol; 2008 Jan; 121(1):13-21; quiz 22-3. PubMed ID: 18206502
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune arthritis: the interface between the immune system and joints.
Komatsu N; Takayanagi H
Adv Immunol; 2012; 115():45-71. PubMed ID: 22608255
[TBL] [Abstract][Full Text] [Related]
20. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Eisenberg R; Albert D
Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
